---
title: "Sanofi launches insulin in the U.S. with a \"Pay $35 per month\" plan"
description: "Sanofi US announced on September 26 that its \"Insulin Savings Program\" will significantly expand its coverage, allowing any U.S. patient with a valid prescription to purchase a 30-day supply of any Sa"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/259065222.md"
published_at: "2025-09-26T12:14:10.000Z"
---

# Sanofi launches insulin in the U.S. with a "Pay $35 per month" plan

> Sanofi US announced on September 26 that its "Insulin Savings Program" will significantly expand its coverage, allowing any U.S. patient with a valid prescription to purchase a 30-day supply of any Sanofi insulin for $35. The program was initially established for the uninsured and will now be open to all Americans, regardless of their insurance status—including those with commercial insurance or Medicare. The expanded "Insulin Savings Program" now ensures that each U.S. patient pays no more than $35 per month for Sanofi insulin

Sanofi US announced on September 26 that its "Insulin Savings Program" will significantly expand its coverage. Any U.S. patient with a valid prescription can purchase a 30-day supply of any Sanofi insulin for $35. The program was initially established for the uninsured, but it will now be open to all Americans, regardless of their insurance status—including those with commercial insurance or Medicare. The expanded "Insulin Savings Program" now ensures that each U.S. patient pays no more than $35 per month for Sanofi insulin

### Related Stocks

- [SNYNF.US - Sanofi](https://longbridge.com/en/quote/SNYNF.US.md)
- [SNY.US - Sanofi](https://longbridge.com/en/quote/SNY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions | Texas Attorney General Ken Paxton has filed a lawsuit against Sanofi, alleging the company bribed healthcare providers t | [Link](https://longbridge.com/en/news/276391061.md) |
| Sanofi: Beyfortus Study Shows Benefit For Infants Beyond First RSV Season | Sanofi announced that a study on its RSV immunization program using Beyfortus showed a significant reduction in RSV-rela | [Link](https://longbridge.com/en/news/276038221.md) |
| MannKind (MNKD) Valuation Check As Afrezza Pediatric Milestones Open Needle Free Insulin Opportunity | MannKind (MNKD) has enrolled its first pediatric patient in the INHALE-1ST Afrezza study, potentially leading to the fir | [Link](https://longbridge.com/en/news/276150484.md) |
| Nevada sues Kalshi as federal regulators say back off | Nevada sues Kalshi as federal regulators say back off | [Link](https://longbridge.com/en/news/276187694.md) |
| Restore accountability to the inspector general system | The Trump administration's reforms call for accountability in federal agencies, particularly the Council of Inspectors G | [Link](https://longbridge.com/en/news/276257151.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.